Get the Stockscreener App
118.97
0.36%
-0.3881
Overview
News
Price History
Option Chain
Financials
Why CLX Down?
Discussions
Forecast
Stock Split
Dividend History
Clorox Co stock is traded at $118.97, with a volume of 430.27K.
It is down -0.36% in the last 24 hours and up +12.00% over the past month.
Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.
See More
Previous Close:
$119.36
Open:
$118.16
24h Volume:
430.27K
Relative Volume:
0.18
Market Cap:
$14.38B
Revenue:
$7.10B
Net Income/Loss:
$824.00M
P/E Ratio:
18.23
EPS:
6.5244
Net Cash Flow:
$761.00M
1W Performance:
+4.98%
1M Performance:
+12.00%
6M Performance:
-4.76%
1Y Performance:
-19.87%
1-Day Range:
$118.16
$120.49
1-Week Range:
$111.33
$120.87
52-Week Range:
$96.66
$159.04
Clorox Co Stock (CLX) Company Profile
Name
Clorox Co
Sector
Industry
Phone
(510) 271-7000
Address
THE CLOROX COMPANY, OAKLAND, CA
Compare CLX vs PG, UL, CL, EL, KVUE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLX
Clorox Co
|
118.95 | 14.43B | 7.10B | 824.00M | 761.00M | 6.5244 |
|
PG
Procter Gamble Co
|
156.75 | 369.91B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
70.94 | 157.57B | 64.99B | 6.71B | 6.53B | 2.74 |
|
CL
Colgate Palmolive Co
|
93.72 | 76.10B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
EL
Estee Lauder Cos Inc
|
99.08 | 35.98B | 14.67B | -178.00M | 1.14B | -0.5002 |
|
KVUE
Kenvue Inc
|
18.04 | 34.74B | 15.01B | 1.43B | 1.63B | 0.744 |
Clorox Co Stock (CLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-25 | Reiterated | Barclays | Underweight |
| Jan-07-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Nov-06-24 | Upgrade | TD Cowen | Sell → Hold |
| Oct-01-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-23-24 | Initiated | TD Cowen | Sell |
| Jun-24-24 | Initiated | Exane BNP Paribas | Underperform |
| Apr-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Mar-26-24 | Upgrade | Jefferies | Underperform → Hold |
| Mar-01-24 | Resumed | Goldman | Sell |
| Feb-05-24 | Downgrade | DA Davidson | Buy → Neutral |
| Dec-15-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-22-23 | Upgrade | JP Morgan | Underweight → Neutral |
| Nov-13-23 | Initiated | Jefferies | Underperform |
| Nov-06-23 | Upgrade | UBS | Sell → Neutral |
| Nov-02-23 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Oct-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-02-23 | Upgrade | DA Davidson | Neutral → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Hold |
| Aug-03-23 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Feb-17-23 | Initiated | Citigroup | Neutral |
| Oct-18-22 | Initiated | Evercore ISI | Underperform |
| Oct-17-22 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-14-22 | Resumed | BofA Securities | Underperform |
| Jul-13-22 | Initiated | Raymond James | Outperform |
| Feb-04-22 | Downgrade | Atlantic Equities | Neutral → Underweight |
| Feb-04-22 | Reiterated | Deutsche Bank | Hold |
| Feb-04-22 | Reiterated | JP Morgan | Underweight |
| Feb-04-22 | Reiterated | Morgan Stanley | Underweight |
| Feb-04-22 | Reiterated | UBS | Sell |
| Feb-04-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | Bernstein | Mkt Perform → Underperform |
| Jan-26-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-02-21 | Reiterated | DA Davidson | Neutral |
| Nov-02-21 | Reiterated | Deutsche Bank | Hold |
| Nov-02-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-02-21 | Reiterated | Wells Fargo | Underweight |
| Sep-03-21 | Downgrade | Argus | Buy → Hold |
| Aug-04-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Aug-04-21 | Reiterated | Citigroup | Buy |
| Aug-04-21 | Reiterated | Credit Suisse | Neutral |
| Aug-04-21 | Reiterated | Deutsche Bank | Hold |
| Aug-04-21 | Reiterated | Morgan Stanley | Underweight |
| Aug-04-21 | Reiterated | RBC Capital Mkts | Sector Perform |
| Aug-04-21 | Reiterated | UBS | Sell |
| Aug-04-21 | Reiterated | Wells Fargo | Underweight |
| Jun-24-21 | Initiated | UBS | Sell |
| May-03-21 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-18-21 | Downgrade | DA Davidson | Buy → Neutral |
| Feb-19-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-20-21 | Initiated | Bernstein | Mkt Perform |
| Dec-14-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-08-20 | Initiated | Wells Fargo | Overweight |
| Oct-16-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-20 | Initiated | DA Davidson | Buy |
| Mar-19-20 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-16-20 | Upgrade | JP Morgan | Underweight → Overweight |
| Mar-09-20 | Upgrade | Argus | Hold → Buy |
| Oct-03-19 | Reiterated | BofA/Merrill | Neutral |
| Sep-23-19 | Downgrade | Barclays | Equal Weight → Underweight |
| May-20-19 | Downgrade | Argus | Buy → Hold |
| May-02-19 | Reiterated | BofA/Merrill | Neutral |
| May-02-19 | Upgrade | Deutsche Bank | Sell → Hold |
| Apr-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-07-19 | Initiated | Credit Suisse | Outperform |
| Dec-06-18 | Reiterated | BofA/Merrill | Neutral |
| Sep-25-18 | Upgrade | Argus | Hold → Buy |
| Jul-18-18 | Downgrade | Goldman | Neutral → Sell |
| Apr-19-18 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-08-18 | Downgrade | Argus | Buy → Hold |
| Jan-04-18 | Upgrade | BofA/Merrill | Underperform → Neutral |
View All
Clorox Co Stock (CLX) Latest News
The Clorox Company $CLX Shares Sold by Nuance Investments LLC - MarketBeat
The Clorox Company (CLX): A bull case theory - MSN
Clorox (CLX) Is Consistent, Says Jim Cramer - Finviz
Clorox (NYSE:CLX) Rating Increased to Hold at Wall Street Zen - MarketBeat
BofA flags margin uncertainty for Clorox (CLX) after Q2 earnings miss - MSN
The Clorox Company $CLX Shares Sold by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Clorox Posts Mixed Quarterly Results Amid Strategic Acquisition - AD HOC NEWS
TD Cowen Issues Positive Forecast for Clorox (NYSE:CLX) Stock Price - MarketBeat
BofA Flags Margin Uncertainty for Clorox (CLX) After Q2 Earnings Miss - Insider Monkey
Clorox Weighs GOJO Deal And ERP Payoff For Growth Reboot - simplywall.st
Morgan Stanley Increases Clorox (NYSE:CLX) Price Target to $136.00 - MarketBeat
The Clorox Company $CLX Stake Lifted by Ashton Thomas Private Wealth LLC - MarketBeat
Clorox Stock Scrubs Out Its Stain: Is This Household Giant Finally Turning the Corner? - AD HOC NEWS
Clorox to Present at 2026 CAGNY Conference - Finviz
Clorox completes $580 million ERP overhaul to link operations with digital commerce - Digital Commerce 360
Clorox Completes U.S, Canada ERP Upgrade - Consumer Goods Technology
UBS Raises Price Target for Clorox (CLX) Amidst Neutral Rating | - GuruFocus
Citigroup Raises Clorox (CLX) Price Target to $115.00, Maintains Neutral Rating | CLX Stock News - GuruFocus
Akron’s GOJO Industries is ‘strong, strategic fit’ with Clorox, CEO says - Signal Akron
Is Clorox’s ERP Strain And GOJO Deal Altering The Investment Case For Clorox (CLX)? - simplywall.st
CLX Analyst Rating Update: JP Morgan Maintains Neutral, Raises P - GuruFocus
Clorox (CLX) Analyst Rating: Evercore Lowers Price Target | CLX Stock News - GuruFocus
Deutsche Bank Aktiengesellschaft Issues Pessimistic Forecast for Clorox (NYSE:CLX) Stock Price - MarketBeat
Clorox (NYSE:CLX) Price Target Cut to $151.00 by Analysts at Jefferies Financial Group - MarketBeat
Clorox (NYSE:CLX) Price Target Raised to $117.00 at JPMorgan Chase & Co. - MarketBeat
Jefferies & Co Adjusts Clorox Price Target to $151 From $152, Maintains Buy Rating - marketscreener.com
The Clorox Company (NYSE:CLX) Q2 2026 Earnings Call Transcript - Insider Monkey
Why Is Clorox Stock Falling Wednesday?Clorox (NYSE:CLX) - Benzinga
CLX Q4 Deep Dive: Flat Sales Amid Margin Pressure as Clorox Invests in Innovation and Integration - Finviz
Clorox Q2 2026 Earnings: EPS $1.29, Revenue $1.67B | Fiscal ResultsNews and Statistics - IndexBox
Clorox Co (CLX) Q2 2026 Earnings Call Highlights: Navigating Challenges with Strategic Innovation and Growth Plans - GuruFocus
Decoding Clorox Co (CLX): A Strategic SWOT Insight - GuruFocus
The Clorox Company (CLX): A Bull Case Theory - Insider Monkey
Clorox's (NYSE:CLX) Q4 CY2025: Beats On Revenue - Finviz
Clorox: Fiscal Q2 Earnings Snapshot - theheraldreview.com
Clorox to Acquire GOJO Industries, Makers of Purell® - cmmonline.com
Clorox (CLX) misses Q2 earnings estimates - MSN
Clorox (CLX) Q2 Earnings Miss Expectations, Revenue Surpasses Es - GuruFocus
Earnings call transcript: Clorox Q2 2026 sees mixed results and stock dip - Investing.com
Transforming our operations: Clorox completes ERP rollout across US and Canada - The Clorox Company
Clorox Posts Lower Profit on Sales Volume Declines - The Wall Street Journal
Clorox’s (NYSE:CLX) Q4 CY2025: Beats On Revenue - The Globe and Mail
Clorox: Overview of Fiscal Second Quarter Earnings - Bitget
CLOROX CO /DE/ SEC 10-Q Report - TradingView
Clorox Earnings Review: Q2 Summary - Benzinga
Clorox (NYSE:CLX) Posts Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Clorox shares slip 2% as Q2 earnings miss overshadows revenue beat, driven by higher costs - Investing.com Nigeria
Chair and CEO Linda Rendle on Q2 earnings and outlook for FY26 - The Clorox Company
Clorox misses quarterly profit estimates on muted demand for its cleaning products, higher costs - Reuters
Layoff Watch: What are Cyclerion Therapeutics Inc.’s technical support levelsJuly 2025 Sentiment & Short-Term High Return Ideas - baoquankhu1.vn
Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook - Yahoo Finance
Clorox Co Stock (CLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):